125 related articles for article (PubMed ID: 35907586)
1. Inhibition of PTPN21 has antitumor effects in glioma by restraining the EGFR/PI3K/AKT pathway.
Li XQ; Liu BC; Jiang XB; Gao WW; Rong B; Wei Y; Wang FL; Zhao HK; Zhang L
Toxicol Appl Pharmacol; 2022 Sep; 451():116180. PubMed ID: 35907586
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway.
Wei L; Yi Z; Guo K; Long X
J Cell Physiol; 2019 Dec; 234(12):23608-23617. PubMed ID: 31173355
[TBL] [Abstract][Full Text] [Related]
3. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
4. EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway.
Xiao Z; Huang S; Qiu W; Pang M; Zeng X; Xu X; Yang Y; Yang B; Chu L
Brain Res; 2024 May; 1830():148796. PubMed ID: 38341169
[TBL] [Abstract][Full Text] [Related]
5. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
[TBL] [Abstract][Full Text] [Related]
6. MCL1 gene silencing promotes senescence and apoptosis of glioma cells via inhibition of the PI3K/Akt signaling pathway.
Wu DM; Hong XW; Wen X; Han XR; Wang S; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Zheng YL
IUBMB Life; 2019 Jan; 71(1):81-92. PubMed ID: 30296359
[TBL] [Abstract][Full Text] [Related]
7. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
Liao YX; Zhang ZP; Zhao J; Liu JP
Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
[TBL] [Abstract][Full Text] [Related]
8. Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway.
Liu M; Zhang J; Dong H; Wang W
J Cell Physiol; 2019 Nov; 234(11):20879-20887. PubMed ID: 31001861
[TBL] [Abstract][Full Text] [Related]
9. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
[TBL] [Abstract][Full Text] [Related]
10. IL-13 receptor α2 stimulates human glioma cell growth and metastasis through the Src/PI3K/Akt/mTOR signaling pathway.
Tu M; Wange W; Cai L; Zhu P; Gao Z; Zheng W
Tumour Biol; 2016 Nov; 37(11):14701-14709. PubMed ID: 27623944
[TBL] [Abstract][Full Text] [Related]
11. LINC01198 facilitates gliomagenesis through activating PI3K/AKT pathway.
Xie Y; Cheng Y
RNA Biol; 2020 Jul; 17(7):1040-1052. PubMed ID: 32378450
[TBL] [Abstract][Full Text] [Related]
12. MiR-3918 Inhibits Tumorigenesis of Glioma via Targeting EGFR to Regulate PI3K/AKT and ERK Pathways.
Han Y; Wang H
J Mol Neurosci; 2022 Feb; 72(2):433-440. PubMed ID: 35023001
[TBL] [Abstract][Full Text] [Related]
13. Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Sun Z; Xue H; Wei Y; Wang C; Yu R; Wang C; Wang S; Xu J; Qian M; Meng Q; Li G
Clin Sci (Lond); 2019 May; 133(10):1167-1184. PubMed ID: 31076460
[TBL] [Abstract][Full Text] [Related]
14. Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling.
Raufman JP; Shant J; Guo CY; Roy S; Cheng K
J Cell Physiol; 2008 May; 215(2):538-49. PubMed ID: 18064605
[TBL] [Abstract][Full Text] [Related]
15. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
16. EGFR signals to mTOR through PKC and independently of Akt in glioma.
Fan QW; Cheng C; Knight ZA; Haas-Kogan D; Stokoe D; James CD; McCormick F; Shokat KM; Weiss WA
Sci Signal; 2009 Jan; 2(55):ra4. PubMed ID: 19176518
[TBL] [Abstract][Full Text] [Related]
17. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L
Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655
[TBL] [Abstract][Full Text] [Related]
18. Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K/AKT Signaling Pathway.
Zhang Q; Xu B; Hu F; Chen X; Liu X; Zhang Q; Zuo Y
J Mol Neurosci; 2021 Aug; 71(8):1636-1647. PubMed ID: 33876384
[TBL] [Abstract][Full Text] [Related]
19. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
